Khabre branded placeholder image

health

EMA committee recommends 12 medicines at September meeting

EMA’s Committee for Medicinal Products for Human Use issued positive opinions for 12 medicines at its 14–17 September 2026 meeting, including a rabies vaccine, two biosimilars and two generics. The recommendations remain subject to European Commission decisions.

Khabre branded placeholder image

health

EMA committee issues positive opinions for two veterinary vaccines

The EMA’s Committee for Veterinary Medicinal Products adopted positive opinions for Cirbloc, a vaccine for pigs, and AviGate S. Typhimurium, a vaccine for chickens. The committee also advanced guidance on antimicrobial use, pharmacovigilance and user safety.

Khabre branded placeholder image

health

New EU Visudyne supply chain targets end of shortage in 2027

The European Medicines Agency says new manufacturing sites for Visudyne have been approved, reducing reliance on a single US-based active-substance site. Full supply across the European Union is expected to be restored in 2027.